Paving the way for T cell-based immunotherapies in chronic hepatitis E

Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis EJournal of HepatologyVol. 71Issue 4PreviewHepatitis E virus (HEV) infection is the most common cause of acute viral hepatitis in the global population. HEV is an emerging public health risk found in both the developed and developing countries.1,2 There are several genotypes of HEV but only one serotype. Genotypes 1 and 2 only infect...